Home › Funds › Valiant Capital Management, L.P. › GRDN
Valiant Capital Management, L.P. position in GRDN
GUARDIAN PHARMACY SVCS INC · Consumer Staples
Valiant Capital Management, L.P. reported holding 1,186,658 shares of GRDN (GUARDIAN PHARMACY SVCS INC) in its Q2 2026 13F filing — a position valued at US$49.7M, representing 2.80% of its reported portfolio and ranking #9 among its reported holdings. Valiant Capital Management, L.P. has disclosed GRDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Valiant Capital Management, L.P.'s GRDN position evolved
Valiant Capital Management, L.P. first disclosed a stake in GRDN in Q3 2025 at 1,064,722 shares (US$27.9M). The position peaked in Q2 2026 at 1,186,658 shares, worth US$49.7M. Across 4 filings, Valiant Capital Management, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,186,658 shares valued at US$49.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.06M | $27.93M | New |
| Q4 2025 | 1.23M | $37.08M | Add |
| Q1 2026 | 1.19M | $44.69M | Reduce |
| Q2 2026 | 1.19M | $49.69M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GRDN and 13F data
GRDN (GUARDIAN PHARMACY SVCS INC) is a Consumer Staples company. 71 other funds we track also report a position in GRDN — the largest reported positions include BOONE CAPITAL MANAGEMENT LLC (US$29.8M), Aristotle Capital Boston, LLC (US$17.7M), Lisanti Capital Growth, LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GRDN
- BOONE CAPITAL MANAGEMENT LLC 711.94K sh · $29.81M · Q2 2026
- Aristotle Capital Boston, LLC 422.43K sh · $17.69M · Q2 2026
- Lisanti Capital Growth, LLC 152.03K sh · $6.37M · Q2 2026
- MITCHELL CAPITAL MANAGEMENT CO 143.87K sh · $6.02M · Q2 2026
- Crews Bank & Trust 101.13K sh · $4.23M · Q2 2026
- Kiker Wealth Management, LLC 65.60K sh · $2.75M · Q2 2026
More on Valiant Capital Management, L.P.
FAQ
How long has Valiant Capital Management, L.P. held GRDN?
Valiant Capital Management, L.P. has disclosed GRDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Valiant Capital Management, L.P.'s current position in GRDN?
As of Q2 2026, Valiant Capital Management, L.P. holds 1.19M shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $49.69M, representing 2.80% of its reported portfolio and ranking #9.
Has Valiant Capital Management, L.P. been buying or selling GRDN?
In the latest 13F filing (Q2 2026), Valiant Capital Management, L.P. held unchanged its position in GRDN. The position peaked in Q2 2026 at 1.19M shares.
Which other funds hold GRDN?
Other major institutional holders of GRDN include BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, Lisanti Capital Growth, LLC, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.